Diabetes, Vol 48, Issue 6 1264-1269, Copyright © 1999 by American Diabetes Association

ARTICLES

Acute intravenous leptin infusion increases glucose turnover but not skeletal muscle glucose uptake in ob/ob mice

R Burcelin, S Kamohara, J Li, GS Tannenbaum, MJ Charron and JM Friedman
Department of Biochemistry, Albert Einstein College of Medicine, Bronx, New York 10461, USA.

The mouse ob gene encodes leptin, an adipocyte hormone that regulates body weight and energy expenditure. Leptin has potent metabolic effects on fat and glucose metabolism. A mutation of the ob gene results in mice with severe hereditary obesity and diabetes that can be corrected by treatment with the hormone. In lean mice, leptin acutely increases glucose metabolism in an insulin-independent manner, which could account, at least in part, for some of the antidiabetic effect of the hormone. To investigate further the acute effect of leptin on glucose metabolism in insulin-resistant obese diabetic mice, leptin (40 ng x g(-1) x h(-1)) was administered intravenously for 6 h in C57Bl/6J ob/ob mice. Leptin increased glucose turnover and stimulated glucose uptake in brown adipose tissue (BAT), brain, and heart with no increase in heart rate. A slight increase in all splanchnic tissues was also noticed. Conversely, no increase in skeletal muscle or white adipose tissue (WAT) glucose uptake was observed. Plasma insulin concentration increased moderately but neither glucose, glucagon, thyroid hormones, growth hormone, nor IGF-1 levels were different from phosphate-buffered saline-infused C57Bl/6J ob/ob mice. In addition, leptin stimulated hepatic glucose production, which was associated with increased glucose-6-phosphatase activity. Conversely, PEPCK activity was rather diminished. Interestingly, hepatic insulin receptor substrate (IRS)1-associated phosphatidylinositol 3-kinase activity was slightly elevated, but neither the content of glucose transporter GLUT2 nor the phosphorylation state of the insulin receptor and IRS-1 were changed by acute leptin treatment. Hepatic lipid metabolism was not stimulated during the acute leptin infusion, since the content of triglycerides, glycerol, and citrate was unchanged. These findings suggest that in ob/ob mice, the antidiabetic antiobesity effect of leptin could be the result of a profound alteration of glucose metabolism in liver, BAT, heart, and consequently, glucose turnover. Insulin resistance of skeletal muscle and WAT, while not affected by acute leptin treatment, could also be corrected in the long term and account for some of leptin's antidiabetic effects.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				M. Qatanani and M. A. Lazar Mechanisms of obesity-associated insulin resistance: many choices on the menu Genes & Dev., June 15, 2007; 21(12): 1443 - 1455. [Abstract] [Full Text] [PDF]

				J. B. Flowers, A. T. Oler, S. T. Nadler, Y. Choi, K. L. Schueler, B. S. Yandell, C. M. Kendziorski, and A. D. Attie Abdominal obesity in BTBR male mice is associated with peripheral but not hepatic insulin resistance Am J Physiol Endocrinol Metab, March 1, 2007; 292(3): E936 - E945. [Abstract] [Full Text] [PDF]

				F. Andreelli, M. Foretz, C. Knauf, P. D. Cani, C. Perrin, M. A. Iglesias, B. Pillot, A. Bado, F. Tronche, G. Mithieux, et al. Liver Adenosine Monophosphate-Activated Kinase-{alpha}2 Catalytic Subunit Is a Key Target for the Control of Hepatic Glucose Production by Adiponectin and Leptin But Not Insulin Endocrinology, May 1, 2006; 147(5): 2432 - 2441. [Abstract] [Full Text] [PDF]

				Y. Toyoshima, O. Gavrilova, S. Yakar, W. Jou, S. Pack, Z. Asghar, M. B. Wheeler, and D. LeRoith Leptin Improves Insulin Resistance and Hyperglycemia in a Mouse Model of Type 2 Diabetes Endocrinology, September 1, 2005; 146(9): 4024 - 4035. [Abstract] [Full Text] [PDF]

				D. C. W. Lau, B. Dhillon, H. Yan, P. E. Szmitko, and S. Verma Adipokines: molecular links between obesity and atheroslcerosis Am J Physiol Heart Circ Physiol, May 1, 2005; 288(5): H2031 - H2041. [Abstract] [Full Text] [PDF]

				R. Suzuki, K. Tobe, M. Aoyama, A. Inoue, K. Sakamoto, T. Yamauchi, J. Kamon, N. Kubota, Y. Terauchi, H. Yoshimatsu, et al. Both Insulin Signaling Defects in the Liver and Obesity Contribute to Insulin Resistance and Cause Diabetes in Irs2-/- Mice J. Biol. Chem., June 11, 2004; 279(24): 25039 - 25049. [Abstract] [Full Text] [PDF]

				W. Huang, N. Dedousis, B. A. Bhatt, and R. M. O'Doherty Impaired Activation of Phosphatidylinositol 3-Kinase by Leptin Is a Novel Mechanism of Hepatic Leptin Resistance in Diet-induced Obesity J. Biol. Chem., May 21, 2004; 279(21): 21695 - 21700. [Abstract] [Full Text] [PDF]

				G. A. Wittert, H. Turnbull, P. Hope, J. E. Morley, and M. Horowitz Leptin prevents obesity induced by a high-fat diet after diet-induced weight loss in the marsupial S. crassicaudata Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2004; 286(4): R734 - R739. [Abstract] [Full Text] [PDF]

				M. G. Myers Jr. Leptin Receptor Signaling and the Regulation of Mammalian Physiology Recent Prog. Horm. Res., January 1, 2004; 59(1): 287 - 304. [Abstract] [Full Text]

				R. A. Velliquette, R. J. Koletsky, and P. Ernsberger Plasma Glucagon and Free Fatty Acid Responses to a Glucose Load in the Obese Spontaneous Hypertensive Rat (SHROB) Model of Metabolic Syndrome X Experimental Biology and Medicine, March 1, 2002; 227(3): 164 - 170. [Abstract] [Full Text] [PDF]

				H. Duplain, R. Burcelin, C. Sartori, S. Cook, M. Egli, M. Lepori, P. Vollenweider, T. Pedrazzini, P. Nicod, B. Thorens, et al. Insulin Resistance, Hyperlipidemia, and Hypertension in Mice Lacking Endothelial Nitric Oxide SynthaseNote Added in Proof Circulation, July 17, 2001; 104(3): 342 - 345. [Abstract] [Full Text] [PDF]

				R. Lau, W. D. Blinn, A. Bonen, and D. J. Dyck Stimulatory effects of leptin and muscle contraction on fatty acid metabolism are not additive Am J Physiol Endocrinol Metab, July 1, 2001; 281(1): E122 - E129. [Abstract] [Full Text] [PDF]

				I. Szanto and C. R. Kahn Selective interaction between leptin and insulin signaling pathways in a hepatic cell line PNAS, February 29, 2000; 97(5): 2355 - 2360. [Abstract] [Full Text] [PDF]